- Home
- AMPG vs BCLI Comparison
AMPG vs BCLI Comparison
Compare AMPG & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- BCLI
- Stock Information
- Founded
- AMPG 2002
- BCLI 2000
- Country
- AMPG United States
- BCLI United States
- Employees
- AMPG N/A
- BCLI N/A
- Industry
- AMPG Telecommunications Equipment
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMPG Telecommunications
- BCLI Health Care
- Exchange
- AMPG Nasdaq
- BCLI Nasdaq
- Market Cap
- AMPG 11.8M
- BCLI 13.5M
- IPO Year
- AMPG N/A
- BCLI N/A
- Fundamental
- Price
- AMPG $2.11
- BCLI $2.10
- Analyst Decision
- AMPG Strong Buy
- BCLI Strong Buy
- Analyst Count
- AMPG 1
- BCLI 1
- Target Price
- AMPG $5.00
- BCLI $30.00
- AVG Volume (30 Days)
- AMPG 14.1M
- BCLI 112.5K
- Earning Date
- AMPG 11-14-2024
- BCLI 11-14-2024
- Dividend Yield
- AMPG N/A
- BCLI N/A
- EPS Growth
- AMPG N/A
- BCLI N/A
- EPS
- AMPG N/A
- BCLI N/A
- Revenue
- AMPG $11,667,163.00
- BCLI N/A
- Revenue This Year
- AMPG N/A
- BCLI N/A
- Revenue Next Year
- AMPG $58.88
- BCLI N/A
- P/E Ratio
- AMPG N/A
- BCLI N/A
- Revenue Growth
- AMPG N/A
- BCLI N/A
- 52 Week Low
- AMPG $0.64
- BCLI $1.05
- 52 Week High
- AMPG $6.43
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- AMPG 45.34
- BCLI 49.82
- Support Level
- AMPG $1.78
- BCLI $1.90
- Resistance Level
- AMPG $2.78
- BCLI $2.24
- Average True Range (ATR)
- AMPG 0.96
- BCLI 0.19
- MACD
- AMPG -0.35
- BCLI -0.04
- Stochastic Oscillator
- AMPG 10.63
- BCLI 19.80
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.